SG Americas Securities’s MaxCyte MXCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-49,402
Closed -$77K 3530
2025
Q4
$77K Buy
49,402
+24,467
+98% +$39.1K ﹤0.01% 3288
2025
Q3
$39K Buy
24,935
+1,255
+5% +$2.18K ﹤0.01% 3229
2025
Q2
$52K Sell
23,680
-11,248
-32% -$27.2K ﹤0.01% 2762
2025
Q1
$95K Sell
34,928
-12,877
-27% -$50.8K ﹤0.01% 3067
2024
Q4
$199K Buy
47,805
+9,836
+26% +$37.2K ﹤0.01% 2157
2024
Q3
$148K Buy
37,969
+17,385
+84% +$73.3K ﹤0.01% 2750
2024
Q2
$81K Sell
20,584
-11,194
-35% -$48.2K ﹤0.01% 2593
2024
Q1
$133K Sell
31,778
-16,772
-35% -$78.7K ﹤0.01% 2321
2023
Q4
$228K Buy
48,550
+10,800
+29% +$42K ﹤0.01% 2040
2023
Q3
$118K Buy
+37,750
New +$152K ﹤0.01% 2684
2023
Q2
Sell
-35,516
Closed -$176K 2856
2023
Q1
$176K Buy
35,516
+3,987
+13% +$19.6K ﹤0.01% 2521
2022
Q4
$172K Sell
31,529
-965
-3% -$5.92K ﹤0.01% 2307
2022
Q3
$211K Sell
32,494
-1,274
-4% -$7.11K ﹤0.01% 2285
2022
Q2
$160K Buy
+33,768
New +$166K ﹤0.01% 2822
2022
Q1
Sell
-20,670
Closed -$211K 3282
2021
Q4
$211K Buy
20,670
+9,325
+82% +$100K ﹤0.01% 2648
2021
Q3
$139K Buy
+11,345
New +$171K ﹤0.01% 3480

Other funds holding MXCT

SG Americas Securities's MXCT Position: Q1 2026 in Review

SG Americas Securities sold out of MaxCyte (MXCT) in Q1 2026, closing a stake of 49,402 shares — an estimated $77K sold.

SG Americas Securities first reported a position in MXCT in Q3 2021 and held it in 16 quarters. The position peaked at $228K in Q4 2023. 130 funds tracked by Wall St. Rank hold MXCT as of Q1 2026.

  • SG Americas Securities reported no remaining MaxCyte position as of Q1 2026 after selling out during the quarter.
  • SG Americas Securities sold 49,402 MaxCyte shares in Q1 2026, an estimated $77K.
  • SG Americas Securities first reported a position in MaxCyte in Q3 2021 and held it in 16 quarters.
  • SG Americas Securities's MaxCyte position peaked at $228K in Q4 2023.
  • 130 funds tracked by Wall St. Rank held MaxCyte as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.